The Immune System in Cancer Pathogenesis: Potential Therapeutic Approaches

被引：162
作者：
Pandya, Pankita H. [1 ]
Murray, Mary E. [2 ]
Pollok, Karen E. [3 ]
Renbarger, Jamie L. [4 ]
机构：
[1] Indiana Univ Sch Med, Riley CCRC 2641,705 Riley Hosp Dr, Indianapolis, IN 46202 USA
[2] Indiana Univ Sch Med, Riley CCRC 2623,705 Riley Hosp Dr, Indianapolis, IN 46202 USA
[3] Indiana Univ Sch Med, Res Bldg R4,302D1044 West Walnut St, Indianapolis, IN 46202 USA
[4] Indiana Univ Sch Med, Riley CCRC 2616,705 Riley Hosp Dr, Indianapolis, IN 46202 USA
来源：
JOURNAL OF IMMUNOLOGY RESEARCH | 2016年 / 2016卷
关键词：
REGULATORY T-CELLS; DNA METHYLATION; IMMUNOTHERAPY; COMPLEMENT; MECHANISMS; RECEPTOR; ANGIOGENESIS; MOBILIZATION; ONCOLOGY; INSIGHTS;
D O I：
10.1155/2016/4273943
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
Interplay among immune activation and cancer pathogenesis provides the framework for a novel subspecialty known as immunooncology. In the rapidly evolving field of immunooncology, understanding the tumor-specific immune response enhances understanding of cancer resistance. This review highlights the fundamentals of incorporating precision medicine to discover new immune biomarkers and predictive signatures. Using a personalized approach may have a significant, positive impact on the use of oncolytics to better guide safer and more effective therapies.
引用
收藏
页数：13
相关论文
共 76 条
  • [1] Big opportunities for small molecules in immuno-oncology
    Adams, Jerry L.
    Smothers, James
    Srinivasan, Roopa
    Hoos, Axel
    [J]. NATURE REVIEWS DRUG DISCOVERY, 2015, 14 (09) : 603 - 622
  • [2] DNA Methylation and Cancer Development: Molecular Mechanism
    Akhavan-Niaki, Haleh
    Samadani, Ali Akbar
    [J]. CELL BIOCHEMISTRY AND BIOPHYSICS, 2013, 67 (02) : 501 - 513
  • [3] [Anonymous], JANEWAYS IMMUNOBIOLO
  • [4] [Anonymous], CANC DISCOVERY
  • [5] Combining immunotherapy with oncogene-targeted therapy: a new road for melanoma treatment
    Aris, Mariana
    Marcela Barrio, Maria
    [J]. FRONTIERS IN IMMUNOLOGY, 2015, 6
  • [6] Different clinical features of primary and secondary tumor's in patients with multiple malignancies
    Artac, M
    Bozcuk, H
    Ozdogan, M
    Demiral, AN
    Sarper, A
    Samur, M
    Savas, B
    [J]. TUMORI JOURNAL, 2005, 91 (04): : 317 - 320
  • [7] Tracing the cellular origin of cancer
    Blanpain, Cedric
    [J]. NATURE CELL BIOLOGY, 2013, 15 (02) : 126 - 134
  • [8] Immunotherapy: Making the case for precision medicine
    Bluestone, Jefrey A.
    Tang, Qizhi
    [J]. SCIENCE TRANSLATIONAL MEDICINE, 2015, 7 (280)
  • [9] Little patients, losing patience: pediatric cancer drug development
    Boklan, Jessica
    [J]. MOLECULAR CANCER THERAPEUTICS, 2006, 5 (08) : 1905 - 1908
  • [10] Buchsel Patricia C, 2002, Clin J Oncol Nurs, V6, P198
12345678